ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic Tests"

  • Abstract Number: 520 • 2013 ACR/ARHP Annual Meeting

    Chronic Obstructive Pulmonary Disease Is Very Common in Primary Sjögren’s Syndrome

    Anna M. Nilsson1, Elke Theander2, Roger Hesselstrand3, Eeva Piitulainen4, Sandra Diaz5, Olle Ekberg5, Per Wollmer6 and Thomas Mandl7, 1Dept of Rheumatology, Skane University Hospital Malmo, Lund University, Malmo, Sweden, 2Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology, Lund University, Lund, Sweden, 4Dept of Lung medicine, Lund University & Skåne University Hospital, Malmö, Sweden, 5Dept of Radiology, Skåne University Hospital Malmo, Lund University, Malmö, Sweden, 6Dept of Clinical Physiology, Skane University Hospital Malmo, Lund University, Malmö, Sweden, 7Dept of Rheumatology, Skåne University Hospital Malmo, Lund University, Sweden, Malmö, Sweden

    Background/Purpose: To study the prevalence of chronic obstructive pulmonary disease (COPD) in patients with primary Sjögren's syndrome (pSS) and its association with respiratory symptoms, pulmonary…
  • Abstract Number: 183 • 2013 ACR/ARHP Annual Meeting

    The Performance Of a Point Of Care Test For Detection Of Anti-Mutated Citrullinated Vimentin and Rheumatoid Factor In Early Rheumatoid Arthritis

    Preeda Rojanasantikul1, Prapa Pattrapornpisut2, Kulvara Anuruckparadorn3 and Wanruchada Katchamart1, 1Division of Rheumatology, Department of Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Department of Internal Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 3Department of Transfusion Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Background/Purpose: Besides rheumatoid factor (RF), anti-cyclic citrullinated peptide antibody (ACPA), a newer serologic marker, was added to the new American College of Rheumatology (ACR)/European League…
  • Abstract Number: 2553 • 2013 ACR/ARHP Annual Meeting

    The Clinical Value Of Testing For Aphl, a New ELISA Kit With a Unique Phospholipid Mixture In Patients With Systemic Lupus Erythematosus (SLE)

    Savino Sciascia1, Giovanni Sanna2, Veronica Murru3, Munther A. Khamashta4 and Maria Laura Bertolaccini3, 1Department of Rare, Immunologic, Hematologic and Immunohematologic Diseases, Centro di Immunopatologia e Documentazione su Malattie rare, Torino, Italy, 2Louise Coote Lupus Unit, St. Thomas' Hospital, London, United Kingdom, 3Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 4Lupus Research Unit, The Rayne Institute, St Thomas Hospital, Kings College London School of Medicine, London, United Kingdom

    Background/Purpose:  Antibodies directed to APhL (a mixture of phospholipids) have been reported to predict APS more reliably than aCL tests. We designed this study to…
  • Abstract Number: 2525 • 2013 ACR/ARHP Annual Meeting

    An Assay Panel Combining Cell Bound Complement Activation Products With Autoantibodies To Extractable Nuclear Antigens and Mutated Citrullinated Vimentin Helps With The Differential Diagnosis Of Systemic Lupus Erythematosus

    Chaim Putterman1, Richard Furie2, R. Ramsey-Goldman3, Anca Askanase4, Jill P. Buyon5, Kenneth C. Kalunian6, W. Winn Chatham7, Elena M. Massarotti8, Emily C. Somers9, Irene Blanco10, Puja Chitkara11, Nicole Jordan12, Kyriakos A. Kirou13, Arthur Weinstein14, Susan Manzi15, Joseph M. Ahearn16, Claudia Ibarra17, Derren Barken18 and Thierry Dervieux19, 1Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 2North Shore-LIJ Health System, Lake Success, NY, 3Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4NYU School of Medicine, New York, NY, 5Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 6UCSD School of Medicine, La Jolla, CA, 7University of Alabama at Birmingham, Birmingham, AL, 8Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 9IntMed, Environmental Health, and OB/GYN, University of Michigan, Ann Arbor, MI, 10Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 11Rheumatology, SDAMC, San Diego, CA, 12Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 13Hospital for Special Surgery, New York, NY, 14Washington Hospital Center, Washington, DC, 15Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 16Lupus Center of Excellence, West Penn Allegheny Health System, Pittsburgh, PA, 17Clinical Laboratory, Exagen Diagnostics, Vista, CA, 18Exagen Diagnostics, Vista, CA, 19Research and Development, Exagen Diagnostics, Vista, CA

    Background/Purpose: We previously established the value of cell-bound complement activation products (CBCAPS) in the diagnosis of systemic lupus erythematosus (SLE) (CAPITAL study). The purpose of…
  • Abstract Number: 2274 • 2013 ACR/ARHP Annual Meeting

    Assessment Of The Diagnostic Accuracy Of Different Strategies For Health Fair Case-Finding For Undiagnosed Inflammatory Arthritis

    Kaylynn Aiona1, Christopher C. Striebich2, M. Kristen Demoruelle3, Julia J. Rhiannon4, Stuart M. Weisman5, Marie L. Feser3, Lezlie A. Derber5, James H. Goddard6, Stacey Brake6, Jill Lysengen7, Laura Rosseisen7, John E. Hokanson1, Anna E. Baron1, Jill M. Norris8, V. Michael Holers9 and Kevin D. Deane3, 1Colorado School of Public Health, Aurora, CO, 2University of Colorado Denver, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4Rheumatology, University of Colorado School of Medicine, Aurora, CO, 5University of Colorado School of Medicine, Division of Rheumatology, Aurora, CO, 69Health Fair, Denver, CO, 7Arthritis Foundation, Great West Region, Denver Office, Denver, CO, 8Epidemiology, Colorado School of Public Health, Aurora, CO, 9Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose:   Early treatment of inflammatory arthritis (IA), and especially rheumatoid arthritis (RA), leads to improved outcomes, although diagnostic delays may impede timely treatment. We…
  • Abstract Number: 1891 • 2013 ACR/ARHP Annual Meeting

    Proteomic Profile Of Tears: Can It Help To Diagnose Juvenile Arthritis – Associated Uveitis Prior To The Clinical Signs Of Joints Inflammation

    Vyacheslav Chasnyk1, Sergei Nekhai2, Alla Hynes3, Tatiana Ammosova4, Yuri Obukhov4, Ekaterina Gaidar5, Anatolyi Kononov5, Margarita Dubko6, Elena Serogodskaia6 and Tatiana Nikitina5, 1Hospital Pediatry, State Pediatric Medical University, Saint-Petersburg, Russia, 2Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC, 3Eye Care Physicians and Surgeons, Winchester, VA, 4Howard University, Washington, DC, 5Saint-Petersburg State Pediatric Medical University, St. Petersburg, Russia, 6State Pediatric Medical University, Saint-Petersburg, Russia

    Background/Purpose: Approximately 6% of all cases of uveitis arise in children (Nguyen, Foster, 1998). One of the common causes of uveitis is Juvenile Idiopathic Arthritis…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology